Boardroom Alpha
8-K primary document
AIXC · Current Report (Form 8-K) · Filed February 17, 2026

Aixcrypto Holdings Inc8-K exhibit

ex10-3.htm

 

Exhibit 10.3

 

Qualigen Therapeutics, Inc.

5857 Owens Avenue, Suite 300

Carlsbad, CA 92008

 

September 29, 2025

 

Mr. Kevin A. Richardson II

c/o Qualigen Therapeutics, Inc.

5857 Owens Avenue, Suite 300

Carlsbad, CA 92008

 

Dear Mr. Richardson:

 

Reference is made to the appointment today of Kevin A. Richardson II as Co-Chief Executive Officer of Qualigen Therapeutics, Inc. (the “Company”), pursuant to the Lead Investor Agreement dated as of September 19, 2025 between the Company and Faraday Future Intelligent Electric Inc.

 

This letter will confirm the understanding and agreement between the Company and you, that as an inducement to you for continuing, and in consideration of your agreement to continue, in your role as Co-Chief Executive Officer of the Company from the date hereof to a date no earlier than March 31, 2026, in the event of your termination by the Company as a Co-Chief Executive Officer of the Company at any time after March 31, 2026, the Company shall pay to you within sixty (60) days of such date of termination, in addition to any other amounts to which you may entitled as compensation for services rendered to the Company on or prior to the date of such termination, either by agreement or at law, a lump sum payment in an amount equal to your annual base salary on the date hereof ($234,000), less any withholding amount as may be required under applicable law. If the compensation is not paid within 60 days of the date of termination, the Company shall pay default penalty rate of 18% annually.

 

If the foregoing accurately sets forth our understanding and agreement as to the matters set forth above, please execute a copy of this letter where required below and return an executed copy to the undersigned.

 

  Very truly yours,
   
  Qualigen Therapeutics, Inc.
     
  By: /s/ Campbell Becher
  Name: Campbell Becher
  Title: President

 

Acknowledged and Agreed this  
29th day of September, 2025  
   
/s/ Kevin A. Richardson II  
Kevin A. Richardson II  

 

 

Disclaimer

The opinions and information contained herein have been obtained or derived from sources believed to be reliable, but Boardroom Alpha cannot guarantee its accuracy and completeness, and that of the opinions based thereon.

This report contains opinions and is provided for informational purposes only – it does not constitute investment, legal or tax advice. You should not rely solely upon the research herein for purposes of transacting securities or other investments, and you are encouraged to conduct your own research and due diligence, and to seek the advice of a qualified securities professional before you make any investment.

None of the information contained in this report constitutes, or is intended to constitute a recommendation by Boardroom Alpha of any particular security or trading strategy or a determination by Boardroom Alpha that any security or trading strategy is suitable for any specific person. To the extent any of the information contained herein may be deemed to be investment advice, such information is impersonal and not tailored to the investment needs of any specific person.

No representation or warranty, expressed or implied, is made on behalf of Boardroom Alpha as to the accuracy or completeness of the information contained herein. Boardroom Alpha does not accept any liability for any direct, indirect or consequential loss or damage suffered by any person as a result of relying on all or any part of this research and any liability is expressly disclaimed.

Full disclaimer